BIOLASE (NASDAQ:BIOL) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of BIOLASE (NASDAQ:BIOL) in a research note issued to investors on Tuesday morning. The firm issued a sell rating on the medical technology company’s stock.

Other equities analysts have also issued reports about the stock. Benchmark reiterated a “speculative buy” rating and set a $0.40 target price on shares of BIOLASE in a research report on Wednesday, October 2nd. Ascendiant Capital Markets reduced their price objective on BIOLASE from $3.50 to $2.00 and set a “buy” rating on the stock in a report on Tuesday, September 3rd.

BIOLASE Price Performance

BIOLASE stock opened at $0.01 on Tuesday. The stock has a 50-day simple moving average of $0.03 and a 200 day simple moving average of $0.08. The stock has a market capitalization of $230,508.30, a price-to-earnings ratio of 0.00 and a beta of 0.67. BIOLASE has a 12-month low of $0.02 and a 12-month high of $1.94.

Institutional Inflows and Outflows

An institutional investor recently raised its position in BIOLASE stock. Virtu Financial LLC boosted its holdings in BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 143,537 shares of the medical technology company’s stock after buying an additional 131,248 shares during the period. Virtu Financial LLC owned approximately 0.43% of BIOLASE worth $27,000 as of its most recent SEC filing. 8.79% of the stock is owned by hedge funds and other institutional investors.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.